Efficacy and safety of lacosamide was evaluated in an exclusively Asian population.
Greater median changes in POS frequency were observed with lacosamide vs placebo.
Significant percent reductions in seizure frequency over placebo were observed.
Safety data in this Asian population were consistent with previous pivotal studies.